Streetbeat News

TCNNF

Trulieve Cannabis Corp

Employees

9,000

Industry

Medicinal and Botanical Manufacturing

Open

7.21

Mkt cap

1.5B

Volume

276K

High

7.85

P/E Ratio

-10.92

52-wk high

14.50

Low

7.21

Div yield

N/A

52-wk low

4.75

The cannabis sector experienced significant movement on April 24, 2024, with numerous companies seeing notable changes in their stock prices. AusCann Group Holdings led the gainers with a 235.71% increase, while Blueberries Medical topped the losers, declining by 23.84%. Notably, 22nd Century Group and Greenlane Holdings were among the few NASDAQ-listed companies mentioned, with respective increases of 10.18% and a decrease of 8.17%.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 8:30 pm

Marijuana stocks experienced significant movements on April 23, 2024, with notable gains and losses across the sector. Aurora Cannabis, Canopy Growth, GrowGeneration, SNDL, Village Farms Intl, Tilray Brands, Cronos Group, and Cara Therapeutics were among the US-listed companies that saw their stock prices move. The sector's volatility highlights the dynamic nature of the cannabis industry, with several companies posting double-digit percentage changes in their stock prices.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 8:30 pm

Federal OSHA experts emphasized the need for safety strategies in the cannabis industry following the first occupational-related cannabis death in Massachusetts. Trulieve (OTCQX:TCNNF) faced a lawsuit after an employee died from asthma exacerbated by workplace exposure. OSHA's webinar highlighted the importance of industry involvement in training and reporting symptoms of occupational allergy. Despite cannabis being federally illegal, OSHA standards still apply to employers in the industry, stressing the need for marking hazardous chemicals and establishing robust health and safety standards.

Portfolio Pulse from Nina Zdinjak

April 22, 2024 | 3:59 pm

This 4/20, cannabis retailers anticipate record sales, with brands like MariMed's Betty’s Eddies, Cresco's High Supply, Ascend Wellness's Simply Herb, and others leading in various states. The article highlights market leaders in the East, Midwest, California, Nevada, Florida, and New York, with a focus on companies like AYR Wellness, Curaleaf Holdings, Green Thumb Industries, and Trulieve. The pre-roll segment and the competitive landscape in each state are also discussed, indicating a highly anticipated sales surge.

Portfolio Pulse from Nicolás Jose Rodriguez

April 20, 2024 | 1:54 pm

The cannabis stock market saw significant movements on April 19, 2024, with notable gainers including Global Compliance, Affinor Growers, and Corbus Pharmaceuticals, among others. Conversely, several companies experienced declines, such as 1933 Industries, Blueberries Medical, and 22nd Century Group. The fluctuations highlight the volatile nature of the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 8:30 pm

The cannabis sector experienced mixed movements on April 18, 2024, with several companies witnessing significant gains while others faced steep losses. Notable gainers included Canopy Growth, Greenlane Holdings, Aurora Cannabis, and OrganiGram Holdings, with increases of 20.34%, 19.16%, 13.46%, and 4.92% respectively. On the downside, Australis Capital plummeted by 99%, and other companies like Genetic Technologies and Cara Therapeutics also saw notable declines. The fluctuations highlight the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 8:30 pm

Cannabis industry valuations and multiples for major MSOs have increased Y/O/Y, driven by rescheduling prospects. The EV/NTM EBITDA multiples for 14 MSOs showed an aggregate 39% increase, with notable exceptions like Jushi, TerrAscend, and Ascend experiencing declines. Factors influencing these changes include variations in enterprise value and EBITDA estimates, with a general trend towards valuing EBITDA at higher multiples despite a decrease in EBITDA estimates for some. Companies like Cresco and Ascend, showing modest valuation multiples but increased EBITDA expectations, may warrant further investigation.

Portfolio Pulse from Viridian Capital Advisors

April 18, 2024 | 4:19 pm

At the Benzinga Cannabis Capital Conference, the Bellamy Brothers and Trulieve CEO Kim Rivers discussed the placement of a constitutional amendment to legalize recreational cannabis on the Florida November 2024 ballot. Trulieve, a major supporter of the initiative, aims to rally support to meet the 60% vote threshold required for passage. The Bellamy Brothers, advocates for cannabis legalization, shared their personal connection to the cause and emphasized the safety and regulatory benefits of legalizing cannabis compared to alcohol, based on an FDA report.

Portfolio Pulse from Maureen Meehan

April 18, 2024 | 1:08 pm

Florida Governor Ron DeSantis criticized the cannabis legalization amendment set for the November 2024 ballot, suggesting it would lead to public marijuana consumption near schools. He also targeted cannabis companies supporting the amendment, including Trulieve Cannabis Corp and others, for their financial interests in the amendment's passage.

Portfolio Pulse from Maureen Meehan

April 17, 2024 | 11:20 pm

Marijuana stocks saw significant movement on April 17, 2024, with notable gainers including Green Growth Brands and Elixinol Wellness, and losers like Khiron Life Sciences and Item 9 Labs. The movements reflect volatility in the cannabis sector, impacting companies listed on both OTC and major exchanges like NASDAQ and NYSE.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.